Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors. | Arthritis Res Ther;13(1): R25, 2011 Feb 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors.

Rendas-Baum, Regina; Wallenstein, Gene V; Koncz, Tamas; Kosinski, Mark; Yang, Min; Bradley, John; Zwillich, Samuel H.

Affiliation

Rendas-Baum R; QualityMetric Inc., Outcomes Insight Consulting Division, 24 Albion Road, Lincoln, RI 02865, USA.

Arthritis Res Ther ; 13(1): R25, 2011 Feb 16.

Article in En | MEDLINE | ID: mdl-21324169

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2011 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2011 Document type: Article Affiliation country: